Yesterday, InfiCure Bio was announced as the winners in the category "New entrepreneur of the year" at Umeågalan. We are very proud and happy that our work to help cure fibrosis is awarded. This award shows that if you have a great team and a good ide - sky is the limit!
About wpadminThis author has not yet filled in any details.
So far wpadmin has created 34 blog entries.
InfiCure Bio is nominated for Umeågalan again! This time we are one of three companies nominated in the category "New Entrepreneur of the Year", which feels very honorable. We are looking forward to a fun party and we keep our fingers crossed for winning this year. Read about the nominated companies here (in Swedish).
InfiCure Bio has been accepted to Business Swedens Catalyst program, which is a program aimed at helping companies scale globally. The focus for InfiCure Bio is the Korean market and Business Sweden will help InfiCure to evaluate the potential of the Korean market and the interest in the NIF mouse. We are very excited about this [...]
The CEO of InfiCure Bio presented the company at LSX Nordics in Stockholm on August 28th. To watch the presentation click here.
InfiCure Bio will be presenting at the LSX Nordic Congress in Stockholm on August 28th. The company will be presenting during the start up showcase as one of the growth stage private companies.
InfiCure Bio has received additional funding from NLC InfiCure Bio and Partnerinvest Övre Norrland to speed up the validation of additional indications in the NIF mouse. This is a golden opportunity to broaden our customer base and increase the revenue of the company.
InfiCure Bio is pleased to announce that Lena Söderström has been appointed new Chairman of the Board. Lena has longstanding experience from numerous positions in the life science sector and her knowledge, together with her extensive network, is exactly what InfiCure Bio needs right now. We are looking forward to the next step in the [...]
InfiCure Bio will be present at this years EASL in Vienna. Julia will present the NIF mouse and Dan will talk about imaging in livers of NIF mice. If you're at EASL, do not hesitate to contact us to schedule a one-to-one meeting.
InfiCure Bio is happy to announce that the our application for Vinnovas grant "Innovationsprojekt i företag" was funded. In this round of applications, InfiCure Bio was the only company in Västerbotten with an approved application. This grant will aid in a faster market introduction of the NIF mouse as a preclinical model for kidney fibrosis.
Read our new pamphlet on the NIF mouse as a model for studies of liver fibrosis. The NIF mouse can be used both as a model for tests of drugs to treat general liver fibrosis, but also as a model for tests of drugs targeting the late inflammatory and/or fibrotic stages of NASH.